T. Andersen

发表

Development of an Active Site Peptide Analog of α-Fetoprotein That Prevents Breast Cancer

H. Jacobson, T. Andersen, J. Bennett, 2014, Cancer Prevention Research.

AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats.

H. Jacobson, T. Andersen, J. Bennett, 2009, Oncology reports.

A peptide derived from α-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen

H. Jacobson, T. Andersen, J. Bennett, 2002, Proceedings of the National Academy of Sciences of the United States of America.

AFPep: an anti-breast cancer peptide that is orally active

H. Jacobson, T. Andersen, J. Bennett, 2006, Breast Cancer Research and Treatment.

Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture

T. Andersen, B. Festoff, J. Fenton, 1994, Journal of neuroscience research.

Activity of alkylated prolactin and human growth hormone in receptor and cell assays

T. Andersen, K. Ebner, P. Necessary, 1985, Molecular and Cellular Endocrinology.

An α-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen

H. Jacobson, T. Andersen, J. Bennett, 2007, British Journal of Cancer.

Exploiting for Breast Cancer Control a Proposed Unified Mechanism for Reduction of Human Breast Cancer Risk by the Hormones of Pregnancy

H. Jacobson, T. Andersen, J. Bennett, 2006 .

Prevention of N-Methyl-N-Nitrosourea–Induced Breast Cancer by α-Fetoprotein (AFP)–Derived Peptide, a Peptide Derived from the Active Site of AFP

Hung-Yun Lin, H. Jacobson, T. Andersen, 2005, Clinical Cancer Research.

Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.

B. Line, T. Andersen, J. Bennett, 1999, Cancer biotherapy & radiopharmaceuticals.

A Proposed Unified Mechanism for the Reduction of Human Breast Cancer Risk by the Hormones of Pregnancy

H. Jacobson, T. Andersen, J. Bennett, 2009, Cancer Prevention Research.

Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk.

H. Jacobson, T. Andersen, J. Bennett, 2008, Advances in experimental medicine and biology.

Identification of proteins electroblotted to polyvinylidene difluoride membrane by combined amino acid analysis and bioinformatics: An ABRF multicenter study.

P. Hunziker, J. Crabb, N. Denslow, 1999, Journal of biomolecular techniques : JBT.

AWARD NUMBER: W81XWH-15-1-0242 TITLE: Prevention and Treatment of Breast Cancer

Principal Investigator, T. Andersen, 2016 .

Purification of alpha-fetoprotein from human cord serum with demonstration of its antiestrogenic activity.

H. Jacobson, T. Andersen, J. Bennett, 1993, Biochimica et biophysica acta.

Vascular contractile potency of endothelin-1 is increased in the presence of monocytes or macrophages.

A. Malik, T. Andersen, H. Magazine, 1994, The American journal of physiology.

Functional thrombin receptors on human T lymphoblastoid cells.

A. Tordai, E. Gelfand, T. Andersen, 1993, Journal of immunology.

Oxidative and calcium stress regulate DSCR1 (Adapt78/MCIP1) protein.

K. Davies, H. Lin, G. Ermak, 2003, Free radical biology & medicine.

Design and synthesis of biologically active peptides: A ‘tail’ of amino acids can modulate activity of synthetic cyclic peptides

H. Jacobson, T. Andersen, J. Bennett, 2011, Peptides.

A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep.

M. Spinella, A. Malik, T. Andersen, 1993, Journal of applied physiology.

Thrombin receptor 14-amino acid peptide binds to endothelial cells and stimulates calcium transients.

A. Malik, H. Lum, C. Tiruppathì, 1992, The American journal of physiology.

Endothelin‐receptor interactions

M. Spinella, T. Andersen, H. Magazine, 1993, FEBS letters.

Role of external Na+ and cytosolic pH in agonist-evoked cytosolic Ca2+ response in human platelets.

A. Aviv, T. Andersen, J. Fenton, 1994, The American journal of physiology.

Thrombin stimulation of matrix fibronectin

P. Armstrong, T. Andersen, J. Fenton, 1996, Journal of cellular physiology.

Studies on analogs of a peptide derived from alpha-fetoprotein having antigrowth properties.

R. Maccoll, H. Jacobson, T. Andersen, 2001, The journal of peptide research : official journal of the American Peptide Society.

Physical studies on the rabbit hepatic galactoside-binding protein. Effects of calcium and ligands.

R. Hill, T. Andersen, J. Freytag, 1982, The Journal of biological chemistry.

Human orbital fibroblasts in culture bind and respond to endothelin.

H. Lum, T. Andersen, T. Smith, 1993, The American journal of physiology.

Thrombin Prevents the Expression of Inducible Nitric Oxide Synthase in Vascular Smooth Muscle Cells by a Proteolytically-Activated Thrombin Receptor

R. Busse, V. Schini-Kerth, B. Fisslthaler, 1995, Thrombosis and Haemostasis.

Quantitation and identification of proteins by amino acid analysis: ABRF-96AAA collaborative trial

N. Denslow, T. Andersen, S. Cohen, 1997 .

Endothelin-like pulmonary vasoconstrictor peptide release by alpha-thrombin.

A. Malik, T. Andersen, J. Fenton, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Isoproterenol antagonizes endothelial permeability induced by thrombin and thrombin receptor peptide.

T. Andersen, M. Teitler, F. Minnear, 1993, Journal of applied physiology.

The hydrolysis process and the quality of amino acid analysis: ABRF-94AAA collaborative trial

I. Apostol, J. Fox, R. Paxton, 1995 .

Cell Function on Substrates Containing Immobilized Bioactive Peptides

R. Bizios, K. Dee, T. Andersen, 1993 .

Platelet aggregation abnormalities after cardiopulmonary bypass.

M. Huang, T. Andersen, J. Bennett, 1994, Blood.

The binding domain structure of retinoblastoma‐binding proteins

Temple F. Smith, S. Vajda, J. Figge, 1993, Protein science : a publication of the Protein Society.

Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials.

R. Bizios, K. Dee, T. Andersen, 1998, Journal of biomedical materials research.

Surfaces modified with covalently-immobilized adhesive peptides affect fibroblast population motility.

R. Bizios, K. Olbrich, T. Andersen, 1996, Biomaterials.

Topographic analysis of the alpha-subunit of human follicle-stimulating hormone using site-specific antipeptide antisera.

J. Dias, T. Andersen, R. Weiner, 1990, Endocrinology.

Epitope mapping of human follicle stimulating hormone-alpha using monoclonal antibody 3A identifies a potential receptor binding sequence.

J. Dias, T. Andersen, R. Weiner, 1991, Endocrinology.

Determination of subunit contact-associated epitopes of the beta-subunit of human follicle-stimulating hormone.

J. Dias, T. Andersen, D. Vakharia, 1991, Endocrinology.

Mapping of an assembled epitope of human follicle-stimulating hormone-beta utilizing monoclonal antibodies, synthetic peptides, and hormone-receptor inhibition.

J. Dias, T. Andersen, A. O’Shea, 1990, Endocrinology.

Identification of subunit contact sites on the alpha-subunit of lutropin.

J. Dias, T. Andersen, S. R. Krystek, 1991, Biochemistry.

Efficacy and tolerability of AFPep, a cyclic peptide with anti‐breast cancer properties

David M. Jones, M. Wu, Q. Lin, 2018, Toxicology and applied pharmacology.

Proof-of-Concept Study of an Alpha-Fetoprotein-Derived Peptide for the Management of Canine Mammary Cancer

T. Andersen, J. Bennett, A. Hohenhaus, 2023, Animals : an open access journal from MDPI.

Pharmacodynamic and Pharmacokinetic Properties of AFPep, a Novel Peptide for the Treatment of Breast Cancer

Q. Lin, T. Andersen, J. Bennett, 2017, International Journal of Peptide Research and Therapeutics.

A peptide derived from alpha-fetoprotein inhibits the proliferation induced by estradiol in mammary tumor cells in culture.

W. Sierralta, H. Jacobson, T. Andersen, 2008, Oncology reports.

Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.

H. Jacobson, T. Andersen, J. Bennett, 2004, The journal of peptide research : official journal of the American Peptide Society.

Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.

H. Jacobson, T. Andersen, J. Bennett, 2001, The journal of peptide research : official journal of the American Peptide Society.

Alpha-fetoprotein-derived antiestrotrophic octapeptide.

H. Jacobson, T. Andersen, J. Bennett, 2000, Biochimica et biophysica acta.

The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule.

H. Jacobson, T. Andersen, J. Bennett, 1999, Biochimica et biophysica acta.

Breast Cancer Research Undergraduate Summer Training Program

T. Andersen, 2005 .

Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs.

R. Maccoll, H. Jacobson, T. Andersen, 2001, The journal of peptide research : official journal of the American Peptide Society.

Antiestrogenic and anticancer activities of peptides derived from the active site of alpha‐fetoprotein

T. Andersen, J. Bennett, J. Hughes, 2009, Journal of peptide science : an official publication of the European Peptide Society.

Follitropin binding to receptors in testis: Studies on the reversibility and thermodynamics of the reaction

T. Andersen, L. Reichert, L. Curatolo, 1983, Molecular and Cellular Endocrinology.

Thrombin receptor activation peptide induces pulmonary vasoconstriction.

A. Malik, H. Lum, T. Andersen, 1994, The American journal of physiology.

Reaction of the histidines of prolactin with ethoxyformic anhydride. A binding site modification.

T. Andersen, K. Ebner, 1979, The Journal of biological chemistry.

Inhibition of iodine-125-labeled human follitropin binding to testicular receptor by epidermal growth factor and synthetic peptides.

P. Sluss, J. Huston, T. Andersen, 1986, Biochemistry.

Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion

A. Malik, C. Tiruppathì, T. Andersen, 1992, The Journal of cell biology.

Prediction of antigenic sites in follicle-stimulating hormones: difference profiles enhance antigenicity prediction methods.

J. Dias, T. Andersen, L. Reichert, 1985, Endocrinology.

Enhanced endothelialization of substrates modified with immobilized bioactive peptides.

R. Bizios, K. Dee, T. Andersen, 1995, Tissue engineering.

The rational design of thrombin-directed antithrombotics.

A. Malik, T. Andersen, J. Fenton, 1993, Advances in experimental medicine and biology.

Defining minimal requirements for antibody production to peptide antigens.

T. Fuerst, R. Mannino, T. Andersen, 1990, Vaccine.

Termination of endothelin signaling: Role of nitric oxide

M. Goligorsky, A. Malik, T. Andersen, 1994, Journal of cellular physiology.

Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization

M. Goligorsky, A. Malik, H. Lum, 1993, The Journal of cell biology.

Conditions which promote mineralization at the bone-implant interface: a model in vitro study.

R. Bizios, K. Dee, D. Rueger, 1996, Biomaterials.

Follitropin binding to receptors in testis. Modulation by monovalent salts and divalent cations.

T. Andersen, L. Reichert, 1982, The Journal of biological chemistry.

Thermodynamics of follitropin binding to solubilized calf testis receptor.

T. Andersen, L. Reichert, B. Sanborn, 1987, Biochemistry.

Correlation of B coefficient of viscosity for monovalent salts with effects on binding of human follitropin to receptor

T. Andersen, L. Reichert, 1984, Molecular and Cellular Endocrinology.

Effect of nitration on prolactin activities.

T. Andersen, K. Ebner, M. Zamierowski, 1979, Archives of biochemistry and biophysics.

Cysteine and Tryptophan Amino Acid Analysis of ABRF92-AAA

I. Apostol, J. Fox, R. Paxton, 1993 .

Analysis of computer-generated hydropathy profiles for human glycoprotein and lactogenic hormones.

T. Andersen, L. Reichert, S. R. Krystek, 1985, Endocrinology.

Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein.

Katrina W. Lexa, Amanda M. Salisburg, G. Shields, 2007, Journal of the American Chemical Society.

Micropatterned surfaces modified with select peptides promote exclusive interactions with osteoblasts.

R. Bizios, T. Andersen, R Bizios, 2002, Biomaterials.

Design and synthesis of a specific endothelin 1 antagonist: effects on pulmonary vasoconstriction.

M. Spinella, A. Malik, T. Andersen, 1991, Proceedings of the National Academy of Sciences of the United States of America.

A proposed structural model of endothelin.

B. Wallace, M. Spinella, S. Krystek, 1989, Peptide research.

Evaluation of endothelin receptor populations using endothelin-1 biotinylated at lysine-9 sidechain.

M. Goligorsky, A. Malik, T. Andersen, 1991, Biochemical and biophysical research communications.

Duality of plasmin effect on cytosolic free calcium in human platelets.

A. Aviv, T. Andersen, J. Fenton, 1995, The American journal of physiology.

Purification and chemical composition of a low molecular weight follicle-stimulating hormone binding inhibitor from porcine follicular fluid.

P. Sluss, T. Andersen, A. Schneyer, 1989, Biology of reproduction.

Amino acid analysis—recovery from PVDF membranes: ABRF-95AAA collaborative trial

J. W. Fox, K. Yüksel, N. Denslow, 1996 .

Amino Acid Analysis of Phospho-Peptides: Abrf-93AAA

I. Apostol, J. Fox, R. Paxton, 1994 .

Cleavage of a model peptide at its glycine residue by alkaline mercuric oxycyanide.

P. Weber, T. Andersen, S. R. Krystek, 2009, International journal of peptide and protein research.

Design and Synthesis of a Specific Endothelin-1 Antagonist,

M. Spinella, A. Malik, T. Andersen, 1992 .

Characterisation of gene expression caused by the type III epidermal growth factor receptor mutation

T. Andersen, M. W. Pedersen, T. Oerntoft, 2000 .